Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-06T10:44:21.591Z Has data issue: false hasContentIssue false

Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial

Published online by Cambridge University Press:  01 December 2008

Abstract

Type
Corrigendum
Copyright
Copyright © European Society of Anaesthesiology 2008

doi:10.1017/S026502150800447X, Published by Cambridge University Press, 20 May 2008.

Several incorrect references were given in the Discussion section of the paper by G. Godet, first published online 20 May 2008 [1].

The authors apologise for these errors.

Discussion

  • Paragraph 4, line 10; reference to [14,24] should be [15,24].

  • Paragraph 5, line 4; reference to [19] should be [20].

  • Paragraph 5, line 13; reference to [22] should be [23].

  • Paragraph 5, line 17; reference to [18] should be [19].

References

1. Godet G, Lehot J-J, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol Published by Cambridge University Press, 20 May 2008. doi:10.1017/S026502150800447X.CrossRefGoogle Scholar